Metraipolis › archive › dc_a93f01e8ac2f

Distribution of CYP2C19 genetic polymorphisms and pharmacogenomic implications in 11,710 patients with cardiovascular and cerebrovascular conditions: a large… — Europe PMC PMID:42445730

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42445730
DOI
10.3389/fgene.2026.1830873
License (as archived)
solo-consultazione
Archived
2026-10-18T15:22:48.544Z
SHA-256 of the archived text
8b8a72491feaec2ffdc72149e9976bc3776fa00acd73afce4ed87b63b1158a1d
Stable URL of this page
https://metraipolis.com/documento/dc_a93f01e8ac2f

How to cite

Distribution of CYP2C19 genetic polymorphisms and pharmacogenomic implications in 11,710 patients with cardiovascular and cerebrovascular conditions: a large… — Europe PMC PMID:42445730 — Europe PMC (en), https://europepmc.org/article/MED/42445730 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a93f01e8ac2f (Metraipolis archive dc_a93f01e8ac2f, sha256 8b8a72491feaec2ffdc72149e9976bc3776fa00acd73afce4ed87b63b1158a1d)
BibTeX
@misc{dca93f01e8ac2f,
  title = {Distribution of CYP2C19 genetic polymorphisms and pharmacogenomic implications in 11,710 patients with cardiovascular and cerebrovascular conditions: a large… — Europe PMC PMID:42445730},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42445730},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a93f01e8ac2f; sha256 8b8a72491feaec2ffdc72149e9976bc3776fa00acd73afce4ed87b63b1158a1d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42445730. Agents can read the archived copy with the MCP tool read_document.